| ADR Ontology |
| ADR Term |
Secondary hypothyroidism |
| ADR ID |
BADD_A07684 |
| ADR Hierarchy |
|
| Description |
A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. [MeSH] |
| MedDRA Code |
10039840 |
| MeSH ID |
D007037
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Secondary hypothyroidism | Pituitary hypothyroidism | Hypothyroidism | Hypothyroidisms | Primary Hypothyroidism | Hypothyroidism, Primary | Primary Hypothyroidisms | Thyroid-Stimulating Hormone Deficiency | Deficiency, Thyroid-Stimulating Hormone | Hormone Deficiency, Thyroid-Stimulating | Thyroid Stimulating Hormone Deficiency | Thyroid-Stimulating Hormone Deficiencies | TSH Deficiency | Deficiency, TSH | TSH Deficiencies | Secondary Hypothyroidism | Hypothyroidism, Secondary | Secondary Hypothyroidisms | Central Hypothyroidism | Central Hypothyroidisms | Hypothyroidism, Central |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D00269 | Bexarotene | 0.000799% | | | BADD_D02100 | Sunitinib | 0.001066% | |
| The 1th Page 1
Total 1 Pages
|
|
